EHA 2023 Nilotinib and interferon induction therapy plus interferon maintenance in CML patients Read more
EHA 2023 Impact of TKI cessation on quality of life of CML patients across various age groups Read more
CongressUpdate Prognostic factors for maintenance of molecular remission after TKI discontinuation in CML pat... Read more
CongressUpdate Haematologic diseases and potential future treatments: Award winners at the 2022 annual BSTH m... Read more
